Guardant Health Enhances Employee Incentives Through Targeted Equity Grants’
In a move underscoring its commitment to aligning employee interests with shareholder value, Guardant Health, Inc. (Nasdaq: GH), a prominent player in the precision oncology sphere, announced on April 22, 2024, a sizeable issuance of equity-based compensation under Nasdaq Listing Rule 5635(c)(4).
The Compensation Committee of Guardant’s Board of Directors sanctioned the allocation of restricted stock units (RSUs) and non-qualified stock options (NSOs) as part of its strategy to attract and retain key talent essential to its operational and strategic s. In detail, the company granted RSUs covering 215,601 shares of its common stock to 94 newly hired non-executive employees. Each RSU represents an en
Comments